Orchid Pharma Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Orchid Pharma Limited cash flow conversion efficiency. Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs115.10 Million ≈ $1.24 Million USD) by net assets (Rs12.74 Billion ≈ $137.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Orchid Pharma Limited (2004–2026)

Cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2026. This chart illustrates how Orchid Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Orchid Pharma Limited (ORCHPHARMA) stock price for real-time trading data and today's change.

Orchid Pharma Limited Cash Flow Conversion Ratio Explained

Orchid Pharma Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Orchid Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orchid Pharma Limited ranked by their cash flow conversion efficiency. Also see Orchid Pharma Limited stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Guangdong Brandmax Marketing Co Ltd SHE:300805	0.016x
Jiangsu Xiuqiang Glasswork Co SHE:300160	0.030x
BlackRock Core Bond Closed Fund NYSE:BHK	0.030x
Qinghai Huzhu Barley Wine Co Ltd SHE:002646	0.000x
PLAYWAY SA WAR:PLW	0.120x
Beijing Tianyishangjia New Material Corp Ltd SHG:688033	-0.043x
YeaShin International Development Co Ltd TWO:5213	-0.145x
Synmosa Biopharma TWO:4114	0.018x

Annual Cash Flow Conversion Efficiency for Orchid Pharma Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2026. Review Orchid Pharma Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs12.88 Billion ≈ $139.27 Million	Rs1.10 Billion ≈ $11.88 Million	0.085x	+462.76%
2025-03-31	Rs12.67 Billion ≈ $137.05 Million	Rs192.15 Million ≈ $2.08 Million	0.015x	-85.93%
2024-03-31	Rs11.69 Billion ≈ $126.47 Million	Rs1.26 Billion ≈ $13.63 Million	0.108x	+304.58%
2023-03-31	Rs6.89 Billion ≈ $74.47 Million	Rs183.38 Million ≈ $1.98 Million	0.027x	-81.36%
2022-03-31	Rs6.47 Billion ≈ $70.01 Million	Rs924.75 Million ≈ $10.00 Million	0.143x	+295.42%
2021-03-31	Rs6.53 Billion ≈ $70.61 Million	Rs235.86 Million ≈ $2.55 Million	0.036x	-65.76%
2020-03-31	Rs7.66 Billion ≈ $82.84 Million	Rs808.03 Million ≈ $8.74 Million	0.105x	+717.65%
2019-03-31	Rs-7.04 Billion ≈ $-76.14 Million	Rs120.24 Million ≈ $1.30 Million	-0.017x	-47.30%
2018-03-31	Rs-7.92 Billion ≈ $-85.63 Million	Rs91.81 Million ≈ $992.84K	-0.012x	+98.65%
2017-03-31	Rs-4.67 Billion ≈ $-50.48 Million	Rs4.01 Billion ≈ $43.36 Million	-0.859x	-119.85%
2016-03-31	Rs490.45 Million ≈ $5.30 Million	Rs2.12 Billion ≈ $22.95 Million	4.327x	+679.20%
2015-03-31	Rs3.29 Billion ≈ $35.62 Million	Rs-2.46 Billion ≈ $-26.61 Million	-0.747x	-353.59%
2013-03-31	Rs3.81 Billion ≈ $41.16 Million	Rs1.12 Billion ≈ $12.12 Million	0.295x	-52.70%
2012-03-31	Rs11.83 Billion ≈ $127.98 Million	Rs7.37 Billion ≈ $79.71 Million	0.623x	+100.87%
2011-03-31	Rs10.71 Billion ≈ $115.84 Million	Rs3.32 Billion ≈ $35.92 Million	0.310x	+947.20%
2010-03-31	Rs9.38 Billion ≈ $101.40 Million	Rs-343.17 Million ≈ $-3.71 Million	-0.037x	-150.53%
2009-03-31	Rs6.34 Billion ≈ $68.54 Million	Rs459.01 Million ≈ $4.96 Million	0.072x	-77.10%
2008-03-31	Rs6.65 Billion ≈ $71.92 Million	Rs2.10 Billion ≈ $22.74 Million	0.316x	+63.88%
2007-03-31	Rs4.85 Billion ≈ $52.46 Million	Rs936.11 Million ≈ $10.12 Million	0.193x	+1627.98%
2006-03-31	Rs7.76 Billion ≈ $83.88 Million	Rs-97.95 Million ≈ $-1.06 Million	-0.013x	-106.68%
2005-03-31	Rs4.61 Billion ≈ $49.83 Million	Rs870.92 Million ≈ $9.42 Million	0.189x	+667.99%
2004-03-31	Rs4.10 Billion ≈ $44.38 Million	Rs-136.54 Million ≈ $-1.48 Million	-0.033x	--

About Orchid Pharma Limited

NSE:ORCHPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$458.80 Million

Rs42.42 Billion INR

Market Cap Rank

#12329 Global

#613 in India

Share Price

Rs836.45

Change (1 day)

-6.37%

52-Week Range

Rs482.45 - Rs1107.20

All Time High

Rs2527.90